Novabridge BiosciencesNBP
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 28 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings, unchanged from Q3 2024. 5 opened new positions and 7 sold out. The largest holders were HHLR Advisors, LTD. ($5.1M), Morgan Stanley ($3.0M) and SG Americas Securities, LLC ($404K). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q4 2024)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $715K |
| Exits | 7 | $6.9M |
All 13F filers, Q3 2024 → Q4 2024: 4,440,870 shares bought and 6,722,603 shares sold, net −2,281,733 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| HHLR Advisors, LTD. | 0.18% | Reduce -13.4% | 5,980,568 | $5.1M |
| Morgan Stanley | 0.00% | Add +11461.9% | 3,543,384 | $3.0M |
| SG Americas Securities, LLC | 0.00% | New | 475,862 | $404K |
| Two Sigma Advisers, LP | 0.00% | Reduce -13.7% | 430,800 | $366K |
| Two Sigma Investments, LP | 0.00% | Reduce -19.2% | 330,206 | $281K |
| EDBI Pte Ltd | 0.20% | No change | 222,136 | $189K |
| Aberdeen Group plc | 0.00% | No change | 162,580 | $138K |
| Cantor Fitzgerald, L. P. | 0.00% | New | 140,100 | $119K |
| BNP Paribas Financial Markets | 0.00% | New | 109,209 | $93K |
| UBS Group AG | 0.00% | New | 103,054 | $88K |
| Millennium Management | 0.00% | Add +763.1% | 97,749 | $83K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $64K |
| Renaissance Technologies | 0.00% | No change | 63,800 | $54K |
| Dimensional Fund Advisors LP | 0.00% | No change | 58,358 | $50K |
| Barclays PLC | 0.00% | No change | 30,370 | $26K |
| Mariner, LLC | 0.00% | Reduce -8.8% | 28,760 | $24K |
| Geode Capital Management, LLC | 0.00% | No change | 22,037 | $19K |
| HRT Financial LP | 0.00% | New | 13,087 | $11K |
| Goldman Sachs Group Inc. | 0.00% | No change | 10,685 | $9K |
| Freestone Capital Holdings, LLC | 0.00% | No change | 10,000 | $9K |
| Rhumbline Advisers | 0.00% | No change | 1,367 | $1K |
| Legal & General Group Plc | 0.00% | No change | 1,191 | $1K |
| Citadel Advisors | 0.00% | Reduce -99.0% | 931 | $791 |
| SBI Securities Co., Ltd. | 0.00% | — | 905 | $769 |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 566 | $481 |
| Vermillion Wealth Management, Inc. | 0.00% | — | 200 | $170 |
| Citigroup Inc. | 0.00% | No change | 50 | $43 |
| Simplex Trading, LLC | 0.00% | Add +95.2% | 814 | $0 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.